Skip to main content

People in the News: Nov 13, 2009

Bruce Spaulding has joined the Gladstone Institutes as chief of planning strategy. Spaulding recently retired as senior vice chancellor of advancement and planning at the University of California, San Francisco. He previously was chief administrative officer of Fresno County and county manager of Las Vegas' Clark County.

Dirk Laukien has resigned from most of his executive positions at Bruker and its subsidiaries, but will stay on with the company as a senior scientific fellow and member of the board of directors. Laukien will resign from his roles as senior VP of Bruker, and from his directorship at Bruker Optics; as co-president and director jobs at Bruker BioSpin; as director of Bruker BioSpin AG; and as co-CEO of Bruker BioSpin.

The company will reduce his base salary to $100,000. Laukien is resigning from these posts in order to have more free time, Bruker said.

Bruker also has appointed William Knight as COO and Brian Monahan as CFO. Both appointments will take effect on Feb. 1, 2010. Knight currently is CFO and Monahan is chief accounting officer at Bruker. Knight joined the company as treasurer and CFO in 2004, and he is president of the Bruker detection business in the US. Monahan started at Bruker in 2004 and was appointed chief accounting officer and VP of finance earlier this year.

Oxford BioTherapeutics has named Jim Cornett COO of US operations and has appointed Jon Terett to be VP for oncology. Cornett formerly was at Medarex, as VP of business development; and worked at Protein Design Labs as business development director. Terett was involved in drug development at Medarex and he was director of molecular oncology at Oxford Glycosciences.

Microchip Biotechnologies said this week that Jim Blair and Bill Byun have joined its board of directors in connection with an $18.1 million financing round for the company. Blair is a partner at investor Domain Associates and Byun is managing director of investor Samsung Ventures America.

CellCyte Genetics has named Douglas Cerretti to the posts of CSO and director of business development. Cerretti has worked at Immunex, and has served as staff scientist and scientific director at Amgen.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.